alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › china

china

3 studies tagged china, dated 2021-10-27 to 2024-12-23. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China 2024-12-23
  2. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment 2023-06-06
  3. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China 2021-10-27

Studies

3 studies carry this tag.

Date range

2021 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Frontiers in aging neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    The common and distinct risk factors across cognitive decline stages emphasize the need for tailored interventions.

  2. Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-06-06 Biomarkers

    Closing this gap will require the introduction of high-performing blood tests, greater reliance on cerebrospinal fluid (CSF) testing, and expansion of positron emission tomography (PET) capacity.

  3. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Frontiers in aging neuroscience 2021-10-27 Biomarkers

    After adjusting for age, sex, and the apolipoprotein E ( APOE ) alleles, compared to the CN group, the plasma t-tau, and NfL were significantly increased in the AD group ( p < 0.01, Bonferroni correction).

All topic tags with their study counts